As of February 10, 2017 Labflex A/S is once again 100 percent owned by the family Foghsgaard, who has repurchased the majority holding from Norwegian shareholder Credo Partners.
The Foghsgaard family looks forward to working with the employees to develop and strengthen Labflex as an international supplier of customized laboratory solutions.
Malte Foghsgaard, majority shareholder and board member, comments:
"We hope that this will create quietness regarding ownership of the company, so we can focus on creating prosperity for Labflex. We have downscaled our financial ambitions to make room for further development of the business and also reduced the Management Team. Specifically it means that I will step into the board, and our existing CFO Ulrik E. Fink takes over as CEO. The Executive Board will further consist of Sales and Project Director Stig Blicher and Supply Chain Director Lars Hangaard. Overall this is a strong and powerful unit.
Ulrik E. Fink comes from NNE Pharmaplan where he the past 16 years has been the driving force behind the construction of NNE's project skills, including project management control. Ulrik is 44 years old and holds a degree in Economics and a MBA. I am very happy to get Ulrik on board because of his strong international project experience and financial project competence. "